BCL2L1 and osteosarcoma: Wang et al. found that Bcl-xL expression was significantly higher in osteosarcoma tissues than in corresponding non-tumor tissues, and the expression levels of Bcl-xL were correlated with resistance of OS cells to chemo- or radiotherapy-induced apoptosis29.